Year 2020 - 2021
Year 2019 - 2020
Year 2018 - 2019
Year 2017 - 2018
Year 2016 - 2017


Papers

Hospital Authority

Drug Formulary and Samaritan Fund

Year 2020 - 2021



LC Paper No.PaperMeeting date
CB(2)579/20-21(05) Administration's paper on update on means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes 8 January 2021
CB(2)579/20-21(06) Paper on means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes prepared by the Legislative Council Secretariat (updated background brief) 8 January 2021
CB(4)973/20-21(05) Administration's paper on the Hospital Authority Drug Formulary and Drug Subsidy 14 May 2021
CB(4)973/20-21(06) Paper on Drug Formulary of the Hospital Authority and drug subsidies prepared by the Legislative Council Secretariat (updated background brief) 14 May 2021
CB(4)988/20-21(04) Submission on the Hospital Authority Drug Formulary and Drug Subsidy from a member of the public (Chinese version only) 14 May 2021
CB(4)988/20-21(03) Submission on the Hospital Authority Drug Formulary and Drug Subsidy from Cancer Strategy Concern Group (Chinese version only) 14 May 2021
CB(4)988/20-21(02) Submission on the Hospital Authority Drug Formulary and Drug Subsidy from Silveriders (Chinese version only) 14 May 2021
CB(4)1103/20-21(01) Submission on issues relating to women's health from HER2-positive breast cancer patients (Chinese version only) (Circulated to members only) 11 June 2021


Year 2019 - 2020



LC Paper No.PaperMeeting date
CB(2)731/19-20(01) Referral from the Subcommittee on Issues Relating to the Support for Cancer Patients on the implementation of breast cancer screening in Hong Kong (English version only) 20 March 2020


Year 2018 - 2019



LC Paper No.PaperMeeting date
CB(2)214/18-19(01) Administration's paper on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes 19 November 2018
11 December 2018
CB(2)321/18-19(01) Administration's response to issues raised in the letter dated 16 November 2018 from Hon SHIU Ka-chun (Follow-up paper) 19 November 2018
CB(2)279/18-19(01) Letter dated 16 November 2018 from Hon SHIU Ka-chun concerning the review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes (Chinese version only) 19 November 2018
CB(2)231/18-19(05) Paper on the means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes prepared by the Legislative Council Secretariat (background brief) 19 November 2018
CB(2)275/18-19(01) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Patients' Alliance on Healthcare Reform (Chinese version only) 19 November 2018
CB(2)600/18-19(01) Administration's response to the motion passed by the Panel at the special meeting on 11 December 2018 on "Review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes" (Follow-up paper) 11 December 2018
CB(2)963/18-19(01) Administration's supplementary information on Review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes (Follow-up paper) 11 December 2018
CB(2)391/18-19(01) Paper on the means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes prepared by the Legislative Council Secretariat (updated background brief) 11 December 2018
CB(2)391/18-19(05) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from a deputation (PNH 病人權益關注組) (Chinese version only) 11 December 2018
CB(2)391/18-19(06) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from a deputation (同路人小組) (Chinese version only) 11 December 2018
CB(2)472/18-19(02) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from B27 Association (Chinese version only) 11 December 2018
CB(2)391/18-19(02) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Cancer Patient Alliance (Chinese version only) 11 December 2018
CB(2)472/18-19(01) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Civic Party (Chinese version only) 11 December 2018
CB(2)391/18-19(04) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Hong Kong Alliance for Rare Diseases (Chinese version only) 11 December 2018
CB(2)391/18-19(07) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Hong Kong Myeloma Care & Share (Chinese version only) 11 December 2018
CB(2)391/18-19(03) Submission on review findings of means test mechanism for Samaritan Fund and Community Care Fund Medical Assistance Programmes from Patients' Alliance on Healthcare Reform (Chinese version only) 11 December 2018
CB(2)374/18-19(01) Letter dated 29 November 2018 from Dr Hon Fernando CHEUNG requesting the Panel to discuss the safeguarding of the rights of patients with rare diseases through legislation (Chinese version only) 17 December 2018
CB(2)605/18-19(01) Referral from the Public Complaints Office of the Legislative Council Secretariat on policy issues relating to inclusion of drugs for treatment of serious mental disorder in the Drug Formulary of the Hospital Authority (Chinese version only) (Restricted to members only) 21 January 2019


Year 2017 - 2018



LC Paper No.PaperMeeting date
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat (Updated version) 17 July 2017
16 October 2017
20 November 2017
CB(2)1326/17-18(01) Joint letter dated 3 May 2018 from Hon CHAN Han-pan and Dr Hon CHIANG Lai-wan proposing the setting up of a subcommittee under the Panel on issues relating to the support for cancer patients (Chinese version only) 21 May 2018
CB(2)1578/17-18(03) Administration's paper on update on Samaritan Fund and Community Care Fund Medical Assistance Programmes 19 June 2018
CB(2)451/18-19(01) Administration's supplementary information on Samaritan Fund and Community Care Fund Medical Assistance Programmes (Follow-up paper) 19 June 2018
CB(2)1578/17-18(04) Paper on the Samaritan Fund and the Community Care Fund Medical Assistance Programmes prepared by the Legislative Council Secretariat (background brief) 19 June 2018


Year 2016 - 2017



LC Paper No.PaperMeeting date
CB(2)386/16-17(03) Administration's paper on drug management of the Hospital Authority 19 December 2016
CB(2)480/17-18(01) Administration's supplementary information on drug management of the Hospital Authority (Follow-up paper) 19 December 2016
CB(2)370/16-17(01) Letter dated 7 December 2016 from Hon CHAN Han-pan requesting the discussion by the Panel on issues relating to the inclusion of Eculizumab in the Drug Formulary of the Hospital Authority for patients with paroxysmal nocturnal hemoglobinuria (Chinese version only) 19 December 2016
CB(2)437/16-17(01) Letter dated 14 December 2016 from Dr Hon Fernando CHEUNG Chiu-hung concerning the policy on rare diseases and drug for rare diseases (Chinese version only) 19 December 2016
CB(2)386/16-17(04) Paper on drug management of the Hospital Authority prepared by the Legislative Council Secretariat (background brief) 19 December 2016
CB(2)521/16-17(01) Submission from Hong Kong Alliance for Rare Diseases to the Administration expressing views on the 2017 Policy Address and 2017-2018 Budget 4 January 2017*
CB(2)979/16-17(06) Administration's paper on policy on drugs for uncommon disorders 20 March 2017
11 April 2017
IN07/16-17 Information note on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat 20 March 2017
11 April 2017
15 May 2017
CB(2)1022/16-17(11) Letter dated 16 March 2017 from the Hospital Authority to Hong Kong Alliance for Rare Diseases and copied to the Panel (Chinese version only) 20 March 2017
11 April 2017
CB(2)979/16-17(07) Paper on policy on and drugs for rare diseases prepared by the Legislative Council Secretariat (background brief) 20 March 2017
11 April 2017
CB(2)618/17-18(01) Administration's supplementary information on policy on and drugs for rare diseases (Follow-up paper) 11 April 2017
CB(2)2016/16-17(01) Article entitled "Review of 11 national policies for rare diseases in the context of key patient needs" provided by Hong Kong Alliance for Rare Diseases 11 April 2017
CB(2)1326/16-17(01) Joint submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases and Tuberous Sclerosis Complex Association of Hong Kong (Chinese version only) 11 April 2017
CB(2)1128/16-17(07) Joint submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases, Mr TSANG Kin-ping, Dr CHUNG Hon-yin and Mr LAI Ka-wai (Chinese version only) 11 April 2017
CB(2)1128/16-17(05) Joint submission on policy on and drugs for rare diseases from Pauline Kung and Keng Fok (English version only) 11 April 2017
CB(2)1128/16-17(12) Joint submission on policy on and drugs for rare diseases from Prof Tony MOK Shu-kam and Prof Kirsty LEE Wai-chung (English version only) 11 April 2017
CB(2)1128/16-17(04) Joint submission on policy on and drugs for rare diseases from Tuberous Sclerosis Complex Association of Hong Kong, Ms WONG Fung-ming, Ms CHI Yin-lan and Mr Andy CHAN Kin-sing (Chinese version only) (Annex - Circulated to members only) 11 April 2017
CB(2)1128/16-17(02) Submission on policy on and drugs for rare diseases from a deputation (PNH病人權益關注組) (Chinese version only) 11 April 2017
CB(2)1254/16-17(01) Submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases (Chinese version only) 11 April 2017
CB(2)1288/16-17(01) Submission on policy on and drugs for rare diseases from Hong Kong Alliance for Rare Diseases (Chinese version only) 11 April 2017
CB(2)1128/16-17(03) Submission on policy on and drugs for rare diseases from Miss CHAN Wai-sze (Chinese version only) 11 April 2017
CB(2)1128/16-17(10) Submission on policy on and drugs for rare diseases from Miss NG Hei-tung (Chinese version only) 11 April 2017
CB(2)1214/16-17(03) Submission on policy on and drugs for rare diseases from Miss NG Hei-tung (English version only) 11 April 2017
CB(2)1128/16-17(11) Submission on policy on and drugs for rare diseases from Mr FONG Chi-wai (Chinese version only) 11 April 2017
CB(2)1128/16-17(06) Submission on policy on and drugs for rare diseases from Ms Grace WONG Ching-yuen (Chinese version only) 11 April 2017
CB(2)1214/16-17(02) Submission on policy on and drugs for rare diseases from Ms HUI Ching-yee (Chinese version only) 11 April 2017
CB(2)1214/16-17(04) Submission on policy on and drugs for rare diseases from Ms LI Shui-yin (Chinese version only) 11 April 2017
CB(2)1128/16-17(01) Submission on policy on and drugs for rare diseases from Ms Tara Wanye Sam (English version only) 11 April 2017
CB(2)1128/16-17(09) Submission on policy on and drugs for rare diseases from Prof CHAIR Sek-ying (English version only) 11 April 2017
CB(2)1128/16-17(08) Submission on policy on and drugs for rare diseases from Prof CHAN Ho-yin (Chinese version only) 11 April 2017
CB(2)1214/16-17(01) Submission on policy on and drugs for rare diseases from The Civic Party (Chinese version only) 11 April 2017
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat 15 May 2017
FS06/16-17 Supplementary information on rare disease policies in selected places prepared by the Research Office of the Information Services Division of the Legislative Council Secretariat (Updated version) 17 July 2017
16 October 2017


* Issue date